These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 15477876)
1. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention. Zeng L; Kyprianou N Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Zeng L; Rowland RG; Lele SM; Kyprianou N Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584 [TBL] [Abstract][Full Text] [Related]
3. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Man YG; Gardner WA Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698 [TBL] [Abstract][Full Text] [Related]
4. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions. Goel T; Garg S Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015 [TBL] [Abstract][Full Text] [Related]
5. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials. Bostwick DG; Aquilina JW J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613 [TBL] [Abstract][Full Text] [Related]
6. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer? Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Montironi R; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M Nat Clin Pract Urol; 2007 Jun; 4(6):321-32. PubMed ID: 17551536 [TBL] [Abstract][Full Text] [Related]
8. [Apoptosis in pathologic prostatic processes]. Kruslin B Acta Med Croatica; 2009 Oct; 63 Suppl 2():49-52. PubMed ID: 19999547 [TBL] [Abstract][Full Text] [Related]
9. The role of prostate-specific antigen in the chemoprevention of prostate cancer. Crawford ED; DeAntoni EP; Ross CA J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612 [TBL] [Abstract][Full Text] [Related]
10. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases. Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995 [TBL] [Abstract][Full Text] [Related]
11. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia. Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies. Gallo F; Chiono L; Gastaldi E; Venturino E; Giberti C Urology; 2008 Sep; 72(3):628-32. PubMed ID: 18279918 [TBL] [Abstract][Full Text] [Related]
14. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Kronz JD; Shaikh AA; Epstein JI Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955 [TBL] [Abstract][Full Text] [Related]
15. Finasteride decreases the risk of prostatic intraepithelial neoplasia. Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284 [TBL] [Abstract][Full Text] [Related]
16. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach. Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042 [TBL] [Abstract][Full Text] [Related]
17. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. Häggman MJ; Macoska JA; Wojno KJ; Oesterling JE J Urol; 1997 Jul; 158(1):12-22. PubMed ID: 9186314 [TBL] [Abstract][Full Text] [Related]
18. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
19. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800 [TBL] [Abstract][Full Text] [Related]
20. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases. Bostwick DG; Qian J; Maihle NJ Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]